Arax Advisory Partners’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.85K | Buy |
416
+371
| +824% | +$5.21K | ﹤0.01% | 2183 |
|
|
2025
Q1 | $607 | Buy |
45
+2
| +5% | +$27 | ﹤0.01% | 2498 |
|
|
2024
Q4 | $759 | Sell |
43
-1,575
| -97% | -$27.8K | ﹤0.01% | 2227 |
|
|
2024
Q3 | $31K | Buy |
1,618
+728
| +82% | +$13.9K | ﹤0.01% | 909 |
|
|
2024
Q2 | $19.4K | Buy |
+890
| New | +$19.4K | ﹤0.01% | 976 |
|
|
2024
Q1 | – | Sell |
-6
| Closed | -$404 | – | 1364 |
|
|
2023
Q4 | $404 | Buy |
+6
| New | +$404 | ﹤0.01% | 1239 |
|
|
2023
Q2 | – | Sell |
-51
| Closed | -$5.29K | – | 1299 |
|
|
2023
Q1 | $5.29K | Hold |
51
| – | – | ﹤0.01% | 839 |
|
|
2022
Q4 | $5.88K | Hold |
51
| – | – | ﹤0.01% | 747 |
|
|
2022
Q3 | $6K | Hold |
51
| – | – | ﹤0.01% | 753 |
|
|
2022
Q2 | $9K | Hold |
51
| – | – | ﹤0.01% | 668 |
|
|
2022
Q1 | $9K | Hold |
51
| – | – | ﹤0.01% | 670 |
|
|
2021
Q4 | $11K | Hold |
51
| – | – | ﹤0.01% | 637 |
|
|
2021
Q3 | $10K | Hold |
51
| – | – | ﹤0.01% | 641 |
|
|
2021
Q2 | $14K | Buy |
+51
| New | +$14K | ﹤0.01% | 618 |
|
|
2020
Q4 | $10K | Buy |
+51
| New | +$10K | ﹤0.01% | 569 |
|